Malaria vaccine (MSP3-LSP) - Vac4All
Alternative Names: MSP3-LSP aduvanted in Aluminium Hydroxide (AIOH) - Vac4All; MSP3-LSP/AIOH malaria vaccine - Vac4AllLatest Information Update: 31 Oct 2021
At a glance
- Originator Vac4All
- Class Antimalarials; Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Falciparum malaria
Most Recent Events
- 26 Feb 2019 Discontinued - Phase-II for Falciparum malaria (In children, Prevention) in Mali (SC)
- 01 May 2011 Phase-II clinical trials in Falciparum malaria (Prevention, In children) in Mali (SC)